Stories tagged iPS

Mar
29
2009

Plasmid genetic transfer
Plasmid genetic transferCourtesy Mike Jones

Stem cells from skin via virus transfer feared carcinogenic

Embryonic stem (ES) cells are like blank cells that give rise to every type of cell and tissue in the body.

In Nov., 2007, scientists reprogrammed human skin into stem cells. That technique used cancer causing viruses which remained in the created stem cells.

Such genetic baggage posed safety concerns for potential therapies like cell transplants, and confounded work in the lab, as the introduced genes sometimes spurred mutations that interfered with the normal function of induced cells.

Stem cells produced with no viral remnants

Now, by using a plasmid rather than a virus, James Thompson and Junying Yu have converted adult skin cells into pluripotent stems cells that are completely free of vector and transgene sequences.

The resulting cells, says Thomson, are remarkably similar to embryonic stem cells and show the same capacity to proliferate indefinitely in culture and diversify into all the cell types of the human body. Univ of Wisconsin News

Stem cells for tissue regeneration coming soon

This is a major advance toward safely reprogramming cells for clinical use. The new viral vector-free iPS cells will be available to researchers almost immediately through the International Stem Cell Bank at the WiCell Research Institute.

Research paper abstract in Science:
Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

Aug
09
2008

20 types of diseased cells produced via stem cells

Using the new induced pluripotent stem cell (iPS) technique, researchers from Harvard Stem Cell Institute produced a robust new collection of disease-specific stem cell lines. Having these disease-specific iPS cells will allow researchers to watch the development of diseases in petri dishes, outside of the patients. HSCI iPS Core will produce these disease-specific cell lines for use by scientists around the world.

The cell lines the researchers produced carry the genes or genetic components for 10 different diseases, including Parkinson’s Disease, Type I diabetes, Huntington’s Disease, Down Syndrome, a form of combined immunodeficiency (“Bubble Boy’s Disease”), Lesch-Nyhan syndrome, Gaucher’s Disease, and two forms of Muscular Dystrophy, among others. Havard Stem Cell Institute Spotlight

Read the research paper online

The work is described in a paper published in the online edition of the journal Cell. Click here to read the full text of the paper titled, Disease-Specific Induced Pluripotent Stem Cells.The chief researchers were George Q. Daley, associate director of the Stem Cell Program at Children's Hospital Boston, and Chad Cowan and Konrad Hochedlinger of Massachusetts General Hospital.

Learn more by listening to their press conference

Click hear to listen to an 08/06/08 press conference with George Daley and Doug Melton (who is also co-chairman of Harvard's new interfaculty Department of Stem Cell and Regenerative Biology).